Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Mkilloran who wrote (10093)	6/25/1998 9:06:00 PM
From: per strandberg	Read Replies (1) \| Respond to of 23519

mkilloran, a short report from Sweden. I talked to a urologist today. Astra seems to have done a good job, informing uros and GPs about Muse. He had already started writing prescriptions...but, there is NO MUSE yet in the Swedish pharmacies. He said that Astra expected delivery within a couple of weeks. My guess is that the Swedish medical authorities demand FDA approval. Anyway, the Swedish pipeline is still completely empty, so there is no patient response information or scripts numbers yet. Hopefully, the FDA approval will speed up Astra's launch in several new countries. Regards ps